# Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)

> **NCT00997191** · PHASE3 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 12 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **PROCEDURE:** Laser photocoagulation
- **DRUG:** Intravitreal triamcinolone
- **DRUG:** Intravitreal bevacizumab

## Key facts

- **NCT ID:** NCT00997191
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997191, "Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00997191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*